How to Scale Genomics to Transform Precision Diagnostics

How to Scale Genomics to Transform Precision Diagnostics

Kengo Takishima, Chairman and CEO of Baylor Genetics, discusses how collaboration across the healthcare system, broader multiomic approaches, and strong operational integration into routine clinical care are key to improving patient care.

“For innovation to truly scale, it will require deep collaboration and seamless integration across the healthcare ecosystem,” said Kengo Takishima.

Read the full byline on Fast Company’s website.

About Baylor Genetics

Baylor Genetics is a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, from clinical-grade genomic sequencing to expert interpretation, including Whole Genome Sequencing, Whole Exome Sequencing, and focused panels. Baylor Genetics combines rapid and comprehensive precision diagnostics options with the support of genetic counselors to help clinicians avoid a lengthy diagnostic odyssey for their patients, guide medical management, and ensure no patient with a genetic disorder gets left behind. Baylor Genetics’ testing menu covers family planning, pregnancy, neonatal and pediatric testing, oncology, pharmacogenomics and many other specialized testing options. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states.

PR Contact
SVM PR
[email protected]
(401) 490-9700

image_print